MENU
TPST
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tempest Therapeutics (TPST) Ownership - Who owns Tempest Therapeutics?
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
2000 Sierra Point Parkway
Phone
+1 415 798-8589
Employees
17
Web
https://www.tempesttx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
24.34M
P/E Ratio
N/A
Total Cash
21.51M
Projected Growth
N/A
Total Debt
13.11M
Revenue
N/A
Risk (Beta)
-3.35
Dividend Yield
N/A
Total Cash/Share
5.84
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TPST
Capitalization
24.3M
P/E Ratio
N/A
Risk (Beta)
-3.35
Dividend Yield
N/A
Total Cash
21.5M
Total Cash/Share
5.84
Total Debt
13.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
11.1M
P/B Ratio
2.19
Cash Flow
N/A
Earnings
-18.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
1.70
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-43.32M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-117.06
Shares Held By Institutions
4.77M
Shares Outstanding - Current
3.68M
Total Liabilities
21M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-39.070
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
2000 Sierra Point Parkway
Phone
+1 415 798-8589
Employees
17
Web
https://www.tempesttx.com